Shire isn't the most famous company in the FTSE100 by a very long chalk, but that might be part of its success story.
Life sciences companies are always a punt, but there is a lot to be said for Verona Pharma here. This is not least because the diseases and disorders it wants to tackle are increasingly common.
subscribe to our shows via iTunes, Miro or RSS
